NDC 0143-9742-01 - Oxytocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9742
- Requested NDC
- 0143-9742-01
- Package NDCs from labels
- 0143-9742-01, 0143-9742-25
- Manufacturer
- West-Ward Pharmaceuticals Corp | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2018-12-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxytocin - West-Ward Pharmaceuticals Corp | HIKMA FARMACEUTICA (PORTUGAL), S.A | West-Ward Pharmaceuticals Corp | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2018-12-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9742-01 | Oxytocin | 10 mL in 1 VIAL | INJECTION | 10 | 2 | |
| 0143-9742-25 | Oxytocin | 25 in 1 CARTON | INJECTION | 25 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OXYTOCIN | ACTIVE INGREDIENT | 1JQS135EYN | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| OXYTOCIN | ACTIVE MOIETY | 1JQS135EYN | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| CHLOROBUTANOL | INACTIVE INGREDIENT | HM4YQM8WRC | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | OXYTOCIN INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| hydrocortisone and acetic acid | HYDROCORTISONE AND ACETIC ACID OTIC | Saptalis Pharmaceuticals, LLC | d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32 | 2025-04-25 | Warnings, Adverse reactions | Q40Q9N063P |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| Oxytocin | OXYTOCIN | Fresenius Kabi USA, LLC | 4c4c4b69-8bf7-472c-aafe-29805ba5c965 | 2025-03-24 | Warnings, Adverse reactions | 1791721 1JQS135EYN |
| AeroWash Eyewash | EYEWASH SOLUTION | Aero Healthcare US LLC | a477de08-4301-0ee5-e053-2995a90af79d | 2025-02-26 | Warnings | 059QF0KO0R |
| Advanced Eye Relief Eye Wash | WATER SOLUTION | Bausch & Lomb Incorporated | 9caccce1-4530-441d-bf76-244edeb9dedc | 2025-02-17 | Warnings | 059QF0KO0R |
| Acetic Acid | ACETIC ACID | NuCare Pharmaceuticals,Inc. | f9b4d18b-25f3-604f-e053-6394a90a5531 | 2025-02-10 | Warnings, Adverse reactions | Q40Q9N063P |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products, Inc. | 2d90c8e8-f479-3535-e063-6394a90af122 | 2025-02-07 | Warnings | 059QF0KO0R |
| Endopan HP | ACETICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, BRYONIA (ALBA), CHROMIUM, COLCHICUM AUTUMNALE, LACTICUM ACIDUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, SYZYGIUM JAMBOLANUM, THUJA OCCIDENTALIS, URANIUM NITRICUM | Energique, Inc. | 2bc69a24-c24c-4d12-92bb-7c073edf90dc | 2025-01-24 | Warnings | Q40Q9N063P |
| Medics Choice Soothing Eye Wash | PURIFIED WATER | KC Pharmaceuticals, Inc. | 10e49808-161e-f4ec-e063-6294a90a1775 | 2025-01-19 | Warnings | 059QF0KO0R |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2b9456-8ca0-8253-e053-2a95a90a8f12 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2a34f9-ed95-9921-e053-2995a90a0d59 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2bc45d-e0c8-3af2-e053-2a95a90af0f1 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67169d-6b15-3406-e053-2995a90a60e4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a673225-27be-040a-e053-2a95a90a0a98 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66b61d-82bd-2bbb-e053-2995a90a0b58 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a677063-09d2-8052-e053-2a95a90affae | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a678fac-289c-0f5c-e053-2995a90a0f43 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66da0b-ee7b-2b69-e053-2995a90ae951 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a667d80-d05c-2d18-e053-2995a90a2918 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66e2a9-a661-e847-e053-2a95a90aa304 | 2025-01-09 | Q40Q9N063P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.